PMID 21743057 2011 Genome-wide association study identifies new prostate cancer susceptibility loci.
PMID 18264097 2008 Multiple newly identified loci associated with prostate cancer susceptibility.
PMID 24753544 2014 Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies.
rs9674957 in
CASC17 gene and
Narcolepsy
PMID 19629137 2009 Genome-wide association database developed in the Japanese Integrated Database Project.
rs1859962 in
CASC17 gene and
Nasopharyngeal carcinoma
PMID 20512145 2010 A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci.
rs17765344 in
CASC17 gene and
Prostate carcinoma
PMID 25939597 2015 Two susceptibility loci identified for prostate cancer aggressiveness.
PMID 26034056 2015 A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.
PMID 21743057 2011 Genome-wide association study identifies new prostate cancer susceptibility loci.
PMID 29892016 2018 Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.
PMID 17603485 2007 Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes.
PMID 19767753 2009 Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.
PMID 18264097 2008 Multiple newly identified loci associated with prostate cancer susceptibility.
PMID 24753544 2014 Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies.
rs11654749 in
CASC17 gene and
Respiratory Function Tests
PMID 23284291 2012 Genome-wide joint meta-analysis of SNP and SNP-by-smoking interaction identifies novel loci for pulmonary function.
rs719615 in
CASC17 gene and
Vital capacity
PMID 30595370 2019 Leveraging Polygenic Functional Enrichment to Improve GWAS Power.